Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Precision BioSciences, Inc. (DTIL) had Free Cash Flow of $-11.95M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$10.84M |
|
$-18.44M |
|
-- |
|
$10.84M |
|
$19.91M |
|
$-9.07M |
|
$-9.37M |
|
$-18.44M |
|
$-15.49M |
|
$-18.44M |
|
$-18.44M |
|
$-18.44M |
|
$-15.49M |
|
$-9.07M |
|
$-8.44M |
|
24.63M |
|
24.63M |
|
$-0.75 |
|
$-0.75 |
|
| Balance Sheet Financials | |
$108.69M |
|
$1.18M |
|
$35.20M |
|
$143.89M |
|
$7.75M |
|
$22.42M |
|
$60.03M |
|
$67.79M |
|
$76.10M |
|
$74.97M |
|
$76.10M |
|
25.81M |
|
| Cash Flow Statement Financials | |
$-11.94M |
|
$-0.11M |
|
$0.74M |
|
$137.15M |
|
$125.85M |
|
$-11.31M |
|
$1.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.02 |
|
-- |
|
-- |
|
0.23 |
|
0.29 |
|
100.00% |
|
-83.73% |
|
-83.73% |
|
-- |
|
-170.15% |
|
-170.15% |
|
|
Free Cash Flow |
$-11.95M |
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
2.71 |
|
33.22 |
|
-24.23% |
|
-24.60% |
|
-12.82% |
|
-18.72% |
|
$2.95 |
|
$-0.49 |
|
$-0.48 |
|